Key Segmentation
By Product Type
-
Over-the-Counter Products
-
Prescription Medications
By Condition Type
-
Pediculosis Capitis
-
Pediculosis Corporis
-
Pediculosis Pubis
-
Others
By Route of Administration
-
Oral
-
Topical
-
Others
By Dosage Form
-
Tablets
-
Shampoos
-
Lotions
-
Creams
-
Others
By Distribution Channel
-
Hospital Pharmacies
-
Retail Pharmacies
-
Online Pharmacies
-
Others
By End User
-
Hospitals
-
Specialty Clinics
-
Homecare Settings
-
Others
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America dominated the Lice Treatment Market in 2025.
Over-the-Counter products dominated with approximately 62.3% of revenues in 2025.
Persistent high global head lice infestation prevalence in school-age populations combined with rising treatment resistance to conventional pyrethroid-based products creating clinical demand for next-generation therapeutic alternatives at premium price points.
The Lice Treatment Market was valued at USD 1.15 billion in 2025.
The Lice Treatment Market is expected to grow at a CAGR of 6.26% from 2026 to 2035.